Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease (Q73746124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C E Hollak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E P Corssmit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E Endert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H P Sauerwein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J A Romijn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M H van Oers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

185-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

A less costly regimen of alglucerase to treat Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Accurate Measurement of Liver, Kidney, and Spleen Volume and Mass by Computerized Axial Tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Volume determinations using computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

7 January 2021

Spiral CT of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Treatment of Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Glucose and fat metabolism during short-term starvation in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Decreased glucose oxidation during short-term starvation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Validation of tetrapolar bioelectrical impedance method to assess human body composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

inferred from DOI database lookup

7 January 2021

based on heuristic

The theoretical bases of indirect calorimetry: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Calculation of substrate oxidation rates in vivo from gaseous exchange.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Eicosanoids, signal molecules of liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Biologically active products of stimulated liver macrophages (Kupffer cells).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Indomethacin stimulates basal glucose production in humans without changes in concentrations of glucoregulatory hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Pentoxifylline inhibits basal glucose production in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Changes in Energy Expenditure Resulting from Altered Body Weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900134-4

10.1016/S0002-9343(97)00134-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9316550%20AND%20SRC:MED&resulttype=core&format=json